Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

PVLA

Palvella Therapeutics Inc

May 22 • 04:00PM ET

113.99

-1.93 -1.66 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: ARQT ANAB ZURA KRYS KYMR

| Held by: VTI XBI IWM VXF IWO VTWO VHT VFMO IWC LFSC

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-4.17	Insider Own	29.46%	Shs Outstand	15.74M	Perf Week	-0.22%
Market Cap	1.63B	Forward P/E	-	EPS next Y	-6.43	Insider Trans	-0.45%	Shs Float	10.12M	Perf Month	-10.28%
Enterprise Value	1.39B	PEG	-	EPS next Q	-1.16	Inst Own	83.59%	Short Float	21.45%	Perf Quarter	29.77%
Income	-49.30M	P/S	-	EPS this Y	-49.62%	Inst Trans	33.14%	Short Ratio	7.34	Perf Half Y	17.62%
Sales	0.00M	P/B	7.72	EPS next Y	-15.88%	ROA	-28.73%	Short Interest	2.17M	Perf YTD	8.90%
Book/sh	14.76	P/C	6.24	EPS next 5Y	16.23%	ROE	-34.25%	52W High	151.18 -24.60%	Perf Year	415.56%
Cash/sh	18.26	P/FCF	-	EPS past 3/5Y	53.08% 41.62%	ROIC	-106.76%	52W Low	20.20 464.31%	Perf 3Y	64.14%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	6.35% 6.30%	Perf 5Y	-26.17%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	66.94%	Oper. Margin	-	ATR (14)	7.44	Perf 10Y	-18.11%
Dividend Ex-Date	-	Quick Ratio	5.20	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	44.43	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	28.88	EPS Q/Q	-62.12%	SMA20	-5.61%	Beta	-0.13	Target Price	228.47
Payout	-	Debt/Eq	0.08	Sales Q/Q	-	SMA50	-6.42%	Rel Volume	0.49	Prev Close	115.92
Employees	29	LT Debt/Eq	0.08	Earnings	May 07 BMO	SMA200	23.84%	Avg Volume	295.89K	Price	113.99
IPO	Jan 02, 2015	Option/Short	Yes / Yes	EPS/Sales Surpr.	-28.34% -	Trades		Volume	146,366	Change	-1.66%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)